CUSIP: 29668H104
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,970,859
-
Share change
-
-7,082
-
Total reported value
-
$23,339,000
-
Price per share
-
$2.19
-
Number of holders
-
9
-
Value change
-
-$27,665
-
Number of buys
-
3
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 29668H104?
CUSIP 29668H104 identifies 29668H104 - ESSA PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 29668H104:
Institutional Holders of ESSA PHARMA INC - COM as of Q4 2016
As of 31 Dec 2016,
ESSA PHARMA INC - COM was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,970,859 shares.
The largest 9 holders included
EVENTIDE ASSET MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, Clarus Ventures, LLC, Omega Fund Management, LLC, AWM Investment Company, Inc., ACUTA CAPITAL PARTNERS, LLC, ROYAL BANK OF CANADA, Tower Research Capital LLC (TRC), and BANK OF MONTREAL /CAN/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.